# A Clinical Study of Arfolitixorin in Patients With mCRC

Source: https://onco.cc/trials/nct06922383/  
OnCo record `nct06922383` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of Arfolitixorin in colorectal cancer, run by Isofol Medical AB, now recruiting.

## Summary

A Clinical Study of Arfolitixorin in Patients With mCRC is a phase 1/2 interventional study registered as NCT06922383 by Isofol Medical AB, with 90 participants planned, started 2025-04-10 and due to reach its primary completion in 2028-11-30. Interventions recorded: Arfolitixorin.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06922383
- Phase: 1/2
- Setting: A Phase 1b/2 Study of Arfolitixorin as Part of 5-fluorouracil-based Treatment Regimens in the First-line Treatment of Metastatic Colorectal Cancer
- Sponsor: Isofol Medical AB
- Enrolled: 90

## Sources

- ClinicalTrials.gov NCT06922383: https://clinicaltrials.gov/study/NCT06922383

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)

---
JSON: https://onco.cc/api/v1/entities/nct06922383.json